| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Mar 4, 2025 | REPLIGEN CORP | Senior VP, R&D | Sell | 95.0 | +4,440 | 38.20% | ✗ | $60K |
| Feb 27, 2025 | Feb 28, 2025 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -391 | -3.25% | ✗ | $61.2K |
| Feb 24, 2025 | Feb 25, 2025 | REPLIGEN CORP | Senior VP, R&D | Sell | 46.3 | -275 | -2.24% | ✗ | $45.3K |
| Aug 2, 2024 | Aug 5, 2024 | REPLIGEN CORP | Senior VP, R&D | Sell | 17.5 | -7,148 | -22.53% | ✗ | $1.1M |
| Aug 1, 2024 | Aug 1, 2024 | REPLIGEN CORP | Senior VP, R&D | Sell | 20.0 | -4,465 | -18.82% | ✗ | $739.7K |
| May 14, 2024 | May 15, 2024 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -534 | -2.20% | ✗ | $87.2K |
| Mar 11, 2024 | Mar 12, 2024 | REPLIGEN CORP | Senior VP, R&D | Sell | 20.0 | -3,517 | -12.66% | ✗ | $681.3K |
| Mar 7, 2024 | Mar 7, 2024 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -386 | -1.44% | ✗ | $75.5K |
| Mar 4, 2024 | Mar 6, 2024 | REPLIGEN CORP | Senior VP, R&D | Sell | 51.3 | -135 | -0.50% | ✗ | $26.2K |
| Feb 29, 2024 | Mar 4, 2024 | REPLIGEN CORP | Senior VP, R&D | Sell | 47.5 | -49 | -0.18% | ✗ | $86.9K |
| May 16, 2023 | May 16, 2023 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -710 | -2.93% | ✗ | $109.4K |
| Mar 2, 2023 | Mar 6, 2023 | REPLIGEN CORP | Senior VP, R&D | Sell | 95.0 | +5,812 | 31.49% | ✗ | $234.4K |
| Feb 28, 2023 | Mar 1, 2023 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -358 | -1.90% | ✗ | $62K |
| Feb 28, 2023 | Feb 28, 2023 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -458 | -2.38% | ✗ | $79.4K |
| Aug 11, 2022 | Aug 12, 2022 | REPLIGEN CORP | Senior VP, R&D | Sell | 17.5 | -4,840 | -20.07% | ✗ | $1.2M |
| May 13, 2022 | May 17, 2022 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -712 | -3.42% | ✗ | $107.1K |
| Feb 27, 2022 | Mar 2, 2022 | REPLIGEN CORP | Senior VP, R&D | Sell | 92.5 | +1,700 | 8.89% | ✗ | $498.4K |
| Feb 24, 2022 | Feb 28, 2022 | REPLIGEN CORP | Senior VP, R&D | Sell | 91.3 | +1,938 | 11.28% | ✗ | $35.6K |
| Feb 17, 2022 | Feb 22, 2022 | REPLIGEN CORP | Senior VP, R&D | Sell | 78.8 | +275 | 1.63% | ✗ | $31.9K |
| Dec 14, 2021 | Dec 15, 2021 | REPLIGEN CORP | Senior VP, R&D | Sell | 42.5 | -445 | -2.56% | ✗ | $112.4K |
| Aug 30, 2021 | Sep 2, 2021 | REPLIGEN CORP | Senior VP, R&D | Sell | 17.5 | -4,001 | -18.74% | ✗ | $1.1M |
| Jun 10, 2021 | Jun 14, 2021 | REPLIGEN CORP | Senior VP, R&D | Sell | 17.5 | -6,802 | -24.16% | ✗ | $1.3M |
| May 14, 2021 | May 18, 2021 | REPLIGEN CORP | Senior VP, R&D | Sell | 22.5 | -710 | -2.81% | ✗ | $122.3K |
| Mar 10, 2021 | Mar 12, 2021 | REPLIGEN CORP | Senior VP, R&D | Sell | 17.5 | -8,000 | -24.05% | ✗ | $1.5M |
| Mar 4, 2021 | Mar 8, 2021 | REPLIGEN CORP | Senior VP, R&D | Sell | 20.0 | -2,075 | -7.59% | ✗ | $398.4K |
| Dec 16, 2020 | Dec 18, 2020 | REPLIGEN CORP | Senior VP, R&D | Sell | 22.5 | -435 | -1.67% | ✗ | $81K |
| Aug 6, 2020 | Aug 10, 2020 | REPLIGEN CORP | Senior VP, R&D | Sell | 20.0 | -5,000 | -16.08% | ✗ | $769K |
| May 15, 2020 | May 19, 2020 | REPLIGEN CORP | Senior VP, R&D | Sell | 22.5 | -435 | -1.64% | ✗ | $61.2K |
| May 13, 2020 | May 15, 2020 | REPLIGEN CORP | Senior VP, R&D | Sell | 17.5 | -8,000 | -23.17% | ✗ | $1M |
| Mar 3, 2020 | Mar 5, 2020 | REPLIGEN CORP | Senior VP, R&D | Sell | 20.0 | -3,005 | -10.18% | ✗ | $271.6K |
| Feb 26, 2020 | Feb 27, 2020 | REPLIGEN CORP | Senior VP, R&D | Sell | 36.3 | -195 | -0.74% | ✗ | $16.9K |
| Dec 16, 2019 | Dec 18, 2019 | REPLIGEN CORP | Senior VP, R&D | Sell | 46.3 | -295 | -1.10% | ✗ | $26.7K |
| Mar 1, 2019 | Mar 5, 2019 | REPLIGEN CORP | Senior VP, R&D | Sell | 95.0 | +2,460 | 15.05% | ✗ | $131.1K |
| Feb 28, 2019 | Mar 4, 2019 | REPLIGEN CORP | Senior VP, R&D | Sell | 91.3 | +4,049 | 32.93% | ✗ | $10.9K |
| Dec 18, 2018 | Dec 20, 2018 | REPLIGEN CORP | Senior VP, R&D | Sell | 26.3 | -311 | -2.47% | ✗ | $16.9K |